Chylothorax in Cirrhosis of the Liver

Romero, Santiago; Martín, César Casquet; Hernández, Luís; Verdú, José; Trigo, Celia; Pérez‐Mateo, Miguel; Alemany, Loreto

doi:10.1378/chest.114.1.154

Cited by 98 publications

(38 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…For example, using transjugular intrahepatic portosystemic stent (TIPS) block can induce the information of newly developed chylous ascites and using endoscopic sclerotherapy to treat esophageal varices can reduce the volume of ascites. Cases of chylothorax after liver cirrhosis [11] that originate from chylous effusion can also prove this theory. The research involving eight patients revealed the following: ascites were presented in a milky appearance and separated into layers upon standing; index of biochemistry supported the diagnosis.…”

Section: Discussionmentioning

confidence: 79%

The Effectiveness of the Treatment of Octreotide on Chylous Ascites After Liver Cirrhosis

Zhou

Wang

et al. 2008

Dig Dis Sci

View full text Add to dashboard Cite

Octreotide is a crucial drug used for treating patients with chylous ascites; however, there have been few reports related to octreotide that are being used in cirrhotic patients. Thus, this thesis is designed to determine the effects of octreotide on patients with chylous ascites after liver cirrhosis. Eight patients were diagnosed with chylous ascites, on the basis of laboratory findings on ascites samples, between January 2003 and May 2008. Octreotide was given to the six patients, while the remaining two were treated as a control. All patients had persistent peritoneal drainage with the quantity and quality of the drainage fluid observed once every other day. All the necessary care was individually given to the patients during the therapy. All patients properly received combined therapy including a low-fat and low-sodium diet, and diuretic and peritoneal drainage. The volume of the peritoneal drainage was reduced to zero in one of the six patients who received octreotide therapy, while the other five had the drainage volumes decreased from 2,000 to 50 ml with a clear appearance and negative qualitative analysis of chyle. For those two patients who did not receive octreotide therapy, the conditions of peritoneal drainage seldom changed both from the qualitative and quantitative aspects. In conclusion, Octreotide, along with combined therapy, can rapidly relieve portal hypertension and reduce triglyceride levels in ascites. It appears to be an effective therapy available for the treatment of chylous ascites caused by liver cirrhosis.

show abstract

Section: Discussionmentioning

confidence: 79%

The Effectiveness of the Treatment of Octreotide on Chylous Ascites After Liver Cirrhosis

Zhou

Wang

et al. 2008

Dig Dis Sci

View full text Add to dashboard Cite

show abstract

“…Necrotising pancreatitis has a mortality rate between 5% and 40% depending on the extent of pancreatic involvement [7]. A chylous ascites can gain access to the pleural space via the diaphragmatic pores, leading to a chylothorax [6, 8]. …”

Section: Discussionmentioning

confidence: 99%

A 44-year-old, Caucasian, male nonsmoker with worsening difficulty in breathing and decreased exercise tolerance

Rai

Ionescu

2017

Breathe

View full text Add to dashboard Cite

A 44-year-old, Caucasian man was referred to the respiratory team for worsening difficulty in breathing and decreased exercise tolerance in September 2015. He had been admitted to the general surgery department in December 2014, and treated for an acute severe pancreatitis complicated by a lesser sac collection, necrotic pancreatitis and gastric outlet obstruction. The treatment was conservative and supportive; following his discharge from hospital, he had repeated re-admissions with symptomatic ascites needing drainage via paracentesis.

show abstract

“…The reported incidence of the combined occurrence of chylothorax and chylous ascites has varied from 9% to 55% of chylous effusion [5, 6]. The etiologies of chylothorax and chylous ascites can be nontraumatic and traumatic.…”

Section: Discussionmentioning

confidence: 99%

“…Chylothorax or chylous ascites result from trauma or a malignant condition such as lymphoma. Tuberculosis (TB) can cause cylothorax or chylous ascites [3, 4, 5], but the concurrent occurrence of both manifestations associated with tuberculosis is extremely rare. We report a case of chylothorax and chylous ascites due to TB.…”

Section: Introductionmentioning

confidence: 99%

Simultaneous Chylothorax and Chylous Ascites Due to Tuberculosis

2014

View full text Add to dashboard Cite

Chylothorax or chylous ascites is rare manifestation of tuberculosis. We report a case of simultaneous chylothorax and chylous ascites due to tuberculosis. A 17-year-old girl was admitted with fever, abdominal distention and dyspnea. Chest and abdominal computed tomography revealed bilateral pleural effusion, multifocal nodular consolidation on both lung fields and copious ascites and multiple necrotic lymphadenopathy in the abdominal cavity. Mycobacterium tuberculosis was isolated from sputum and pleural fluid. The patient was treated with anti-tuberculosis medication. Pleural effusion and ascites improved with the medication.

show abstract

Chylothorax in Cirrhosis of the Liver

Cited by 98 publications

References 17 publications

The Effectiveness of the Treatment of Octreotide on Chylous Ascites After Liver Cirrhosis

The Effectiveness of the Treatment of Octreotide on Chylous Ascites After Liver Cirrhosis

A 44-year-old, Caucasian, male nonsmoker with worsening difficulty in breathing and decreased exercise tolerance

Simultaneous Chylothorax and Chylous Ascites Due to Tuberculosis

Contact Info

Product

Resources

About